Related Experiment Video
Updated: Aug 6, 2026
14:32
Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care
Published on: February 16, 2011
Cost-effectiveness analysis in the courts: recent trends and future prospects
1University of Michigan School of Public Health, USA.
Journal of Health Politics, Policy and Law
|May 2, 2001
Summary
Managed care organizations (MCOs) can use cost-effectiveness analysis (CEA) in decision-making. Legal precedents in negligence and product liability cases offer insights into potential MCO liability when applying CEA.
Area of Science:
- Health Law
- Health Economics
- Medical Liability
Background:
- Managed care organizations (MCOs) are increasingly considering cost-effectiveness analysis (CEA) in healthcare decision-making.
- Legal frameworks for MCO liability concerning CEA are not well-established, necessitating examination of analogous legal areas.
- Existing legal doctrines in negligence, product liability, and regulatory challenges provide relevant precedents.
Purpose of the Study:
- To explore how MCOs may integrate CEA into their decision-making processes.
- To assess potential MCO legal liability arising from the application of CEA.
- To analyze how courts have responded to CEA in various legal contexts.
Main Methods:
- Review of legal precedents in general negligence cases using risk-benefit tests.
- Analysis of product liability cases employing risk-utility calculus for design defects.
- Examination of court challenges to government agency use of CEA in regulatory policy.
Main Results:
- Mixed judicial responses to CEA: punitive damages in some product liability cases, but acceptance in negligence without significant negative impact.
- Courts generally defer to agency expertise in incorporating CEA for regulatory policy.
- The application of CEA in product liability has, in some instances, led to punitive damages against manufacturers.
Conclusions:
- The legal implications of MCOs using CEA require careful consideration of established legal principles.
- Setting a clear standard of care for MCOs in the context of CEA is crucial.
- Understanding judicial responses in analogous fields can inform MCO strategies and mitigate liability risks.
Related Concept Videos
01:09Decision Making: P-value Method
The process of hypothesis testing based on the P-value method includes calculating the P- value using the sample data and interpreting it.
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can have a...
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can have a...
01:14Decision Making: Traditional Method
The process of hypothesis testing based on the traditional method includes calculating the critical value, testing the value of the test statistic using the sample data, and interpreting these values.
First, a specific claim about the population parameter is decided based on the research question and is stated in a simple form. Further, an opposing statement to this claim is also stated. These statements can act as null and alternative hypotheses, out of which a null hypothesis would be a...
First, a specific claim about the population parameter is decided based on the research question and is stated in a simple form. Further, an opposing statement to this claim is also stated. These statements can act as null and alternative hypotheses, out of which a null hypothesis would be a...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Statistical Analysis: Overview
When we take repeated measurements on the same or replicated samples, we will observe inconsistencies in the magnitude. These inconsistencies are called errors. To categorize and characterize these results and their errors, the researcher can use statistical analysis to determine the quality of the measurements and/or suitability of the methods.
One of the most commonly used statistical quantifiers is the mean, which is the ratio between the sum of the numerical values of all results and the...
One of the most commonly used statistical quantifiers is the mean, which is the ratio between the sum of the numerical values of all results and the...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...